PubMed

The soluble interleukin-2 receptor: biology, function, and clinical application.

Rubin LA, Nelson DL.

Ann Intern Med. 1990 Oct 15;113(8):619-27. Review.PMID: 2205142 [PubMed - indexed for MEDLINE]Related articles

Clinical significance of soluble interleukin-2 receptor.

Chrobák L.

Acta Medica (Hradec Kralove). 1996;39(1):3-6. Review.PMID: 9106384 [PubMed - indexed for MEDLINE]Related articles

Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.

Srivastava MD, Srivastava A, Srivastava BI.

Leuk Lymphoma. 1994 Jan;12(3-4):241-51.PMID: 7909467 [PubMed - indexed for MEDLINE]Related articles

Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.

Dejica D.

Roum Arch Microbiol Immunol. 2001 Jul-Sep;60(3):183-201.PMID: 12165973 [PubMed - indexed for MEDLINE]Related articles

The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.

Zerler B.

Cancer Cells. 1991 Dec;3(12):471-9. Review.PMID: 1820093 [PubMed - indexed for MEDLINE]Related articles

Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.

Chrobák L, Podzimek K, Plísková L, Kerekes Z, Zák P, Voglová J, Spacek J, Palicka V.

Neoplasma. 1996;43(5):321-5.PMID: 8996552 [PubMed - indexed for MEDLINE]Related articles

Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.

Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, Vermersch A, Fenaux P, Bletry O, Capron M.

Blood. 1991 Nov 15;78(10):2626-32.PMID: 1726707 [PubMed - indexed for MEDLINE]Related articlesFree article

Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.

Bodey B, Psenko V, Lipsey AL, Kaiser HE.

Anticancer Res. 1996 Jan-Feb;16(1):219-24.PMID: 8615612 [PubMed - indexed for MEDLINE]Related articles

Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.

Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M.

Cancer. 1994 Jun 1;73(11):2753-8.PMID: 8194016 [PubMed - indexed for MEDLINE]Related articles

Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.

Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J 3rd, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):807-13.PMID: 9332763 [PubMed - indexed for MEDLINE]Related articlesFree article

IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.

Berghella AM, Pellegrini P, Del Beato T, Adorno D, Casciani CU.

Cancer Biother Radiopharm. 1997 Aug;12(4):265-72.PMID: 10851474 [PubMed - indexed for MEDLINE]Related articles

Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.

Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME.

Am J Pathol. 1994 May;144(5):1089-97.PMID: 8178932 [PubMed - indexed for MEDLINE]Related articlesFree article

Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.

Chang CS, Liu HW, Lin SF, Chen TP.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1989 May;22(2):132-7.PMID: 2605973 [PubMed - indexed for MEDLINE]Related articles

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA.

J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):207-20.PMID: 9486676 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of serum soluble interleukin-2 receptor level in non-Hodgkin's lymphoma: a single center study in Japan.

Kono N, Kanda Y, Yamamoto R, Chizuka A, Suguro M, Hamaki T, Arai C, Matsuyama T, Takezako N, Miwa A, Togawa A.

Leuk Lymphoma. 2000 Mar;37(1-2):151-6.PMID: 10721779 [PubMed - indexed for MEDLINE]Related articles

Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.

Goto H, Tsurumi H, Takemura M, Ino-Shimomura Y, Kasahara S, Sawada M, Yamada T, Hara T, Fukuno K, Goto N, Okuno M, Takami T, Seishima M, Moriwaki H.

J Cancer Res Clin Oncol. 2005 Feb;131(2):73-9. Epub 2004 Oct 21.PMID: 15503137 [PubMed - indexed for MEDLINE]Related articles

Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.

Bien E, Balcerska A.

Biomarkers. 2008 Feb;13(1):1-26. Review.PMID: 17906988 [PubMed - indexed for MEDLINE]Related articles

Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia.

Richards JM, Mick R, Latta JM, Daly K, Ratain MJ, Vardiman JW, Golomb HM.

Blood. 1990 Nov 15;76(10):1941-5.PMID: 1700727 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.

Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H.

Chest. 2003 Jul;124(1):186-95.PMID: 12853522 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome.

Ambrosetti A, Nadali G, Vinante F, Carlini S, Veneri D, Todeschini G, Morosato L, de Sabata D, Chilosi M, Maggi E, et al.

Cancer. 1993 Jul 1;72(1):201-6.PMID: 8508408 [PubMed - indexed for MEDLINE]Related articles